Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

NCT05856409 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05856409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05856409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 10, 2023
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

68ga-fapi, epithelial ovarian cancer, ovarian cancer, positron emission tomography